Viewing Study NCT04337658


Ignite Creation Date: 2025-12-25 @ 12:24 AM
Ignite Modification Date: 2025-12-25 @ 10:28 PM
Study NCT ID: NCT04337658
Status: NOT_YET_RECRUITING
Last Update Posted: 2020-04-08
First Post: 2020-01-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module